meRfi®-GM
Inflammatory Bowel Disease (IBD)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Inflammatory Bowel Disease (IBD) affects more than 6 million people worldwide and constitutes not only a debilitating disease for the patients, but also a significant factor for society due to costs for health care and reduced working capacity.
Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn’s disease, are characterized by chronic idiopathic inflammation of the gastrointestinal tract
Although the pathogenesis of Inflammatory Bowel Disease (IBD)…
References (Sources)
- Compositional changes in the gut mucus microbiota precede the onset of colitis-induced inflammation
- Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study
- Defining disease severity in inflammatory bowel diseases: current and future directions
- Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
- How accurate are clinical activity indices for scoring of disease activity in inflam- matory bowel disease (IBD)?
- Inflammatory bowel disease
- Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics